Date / Time
The goal of this activity is to improve nurses’ ability to optimize patient outcomes through live workshops and an online activity that support a shared decision-making approach between clinicians and patients and that accelerate the awareness and integration of evidence-based therapeutic approaches for the treatment of pancreatic cancer.
This program is intended for oncology nurses and other healthcare providers who care for patients with pancreatic cancer.
Upon completion of this activity, participants should be able to:
- Support patient engagement and decision making through education and communication
- Explain to patients the current guidelines and clinical findings on individualized therapies for newly diagnosed advanced pancreatic cancer
- Evaluate treatment strategies for patients with advanced pancreatic cancer after progression on first-line systemic therapy based on available data and treatment guidelines
- Discuss the available data and ongoing trials investigating FOLFIRINOX or nab-paclitaxel as neoadjuvant and adjuvant therapy
- Evaluate the available clinical evidence for the use of PARP inhibitors to treat pancreatic ductal adenocarcinoma harboring BRCA1/2 or other DNA damage response mutations
- Manage disease-related and treatment-related symptoms for patients with advanced pancreatic cancer
Joint Accreditation Statement
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Nursing Continuing Education
The maximum number of hours awarded for this activity is 1.0 contact hour.
Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.